Q3 SPARC deletion mutant and uses thereof
US7332568B2 · kind B2 · utility
32Cited by
11References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 17, 2006 |
| Grant date | Feb 19, 2008 |
| Priority date | — |
| Expiry date | Mar 11, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides for SPARC polypeptides with a mutation corresponding to a deletion of the third glutamine in the mature form of the human SPARC protein, nucleic acids encoding such polypeptides, antibodies against such polypeptides, and methods of the use of such polypeptides, nucleic acids, and antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.